{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:16:05Z","timestamp":1775175365297,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,5]]},"DOI":"10.7759\/cureus.46536","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T18:06:49Z","timestamp":1696529209000},"source":"Crossref","is-referenced-by-count":4,"title":["Pseudo-Allergies in the Emergency Department: A Common Misdiagnosis of Hypersensitivity Type 1 Allergic Reaction"],"prefix":"10.7759","author":[{"given":"Akram M","family":"Eraky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisha","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2019.40.4274","article-title":"Classification of hypersensitivity reactions","volume":"40","author":"Dispenza MC","year":"2019","unstructured":"Dispenza MC. Classification of hypersensitivity reactions. Allergy Asthma Proc. 2019, 40:470-3. 10.2500\/aap.2019.40.4274","journal-title":"Allergy Asthma Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2020.05.007","article-title":"Oral hypersensitivity reactions","volume":"38","author":"Reinhart JP","year":"2020","unstructured":"Reinhart JP, Stoopler ET, Crawford GH. Oral hypersensitivity reactions. Dermatol Clin. 2020, 38:467-76. 10.1016\/j.det.2020.05.007","journal-title":"Dermatol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13422","article-title":"Food allergy and hypersensitivity reactions in children and adults-a review","volume":"291","author":"Tedner SG","year":"2022","unstructured":"Tedner SG, Asarnoj A, Thulin H, Westman M, Konradsen JR, Nilsson C. Food allergy and hypersensitivity reactions in children and adults-a review. J Intern Med. 2022, 291:283-302. 10.1111\/joim.13422","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2174\/1573396315666191031103714","article-title":"Non-IgE mediated food allergy","volume":"16","author":"Cianferoni A","year":"2020","unstructured":"Cianferoni A. Non-IgE mediated food allergy. Curr Pediatr Rev. 2020, 16:95-105. 10.2174\/1573396315666191031103714","journal-title":"Curr Pediatr Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010809","article-title":"Molecular mechanisms of scombroid food poisoning","volume":"24","author":"Zhernov YV","year":"2023","unstructured":"Zhernov YV, Simanduyev MY, Zaostrovtseva OK, et al.. Molecular mechanisms of scombroid food poisoning. Int J Mol Sci. 2023, 24:80. 10.3390\/ijms24010809","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S284821","article-title":"Pathophysiology of non-IgE-mediated food allergy","volume":"10","author":"Zhang S","year":"2021","unstructured":"Zhang S, Sicherer S, Berin MC, Agyemang A. Pathophysiology of non-IgE-mediated food allergy. Immunotargets Ther. 2021, 10:431-46. 10.2147\/ITT.S284821","journal-title":"Immunotargets Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.03.025","article-title":"Non-IgE-mediated gastrointestinal food allergy","volume":"135","author":"Nowak-W\u0119grzyn A","year":"2015","unstructured":"Nowak-W\u0119grzyn A, Katz Y, Mehr SS, Koletzko S. Non-IgE-mediated gastrointestinal food allergy. J Allergy Clin Immunol. 2015, 135:1114-24. 10.1016\/j.jaci.2015.03.025","journal-title":"J Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.77.10.1335","article-title":"Outbreak of scombroid fish poisoning, Taiwan","volume":"77","author":"Chen KT","year":"1987","unstructured":"Chen KT, Malison MD. Outbreak of scombroid fish poisoning, Taiwan. Am J Public Health. 1987, 77:1335-6. 10.2105\/ajph.77.10.1335","journal-title":"Am J Public Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e235","article-title":"An outbreak of scombroid fish poisoning associated with consumption of yellowtail fish in Seoul, Korea","volume":"33","author":"Kang CR","year":"2018","unstructured":"Kang CR, Kim YY, Lee JI, Joo HD, Jung SW, Cho SI. An outbreak of scombroid fish poisoning associated with consumption of yellowtail fish in Seoul, Korea. J Korean Med Sci. 2018, 33:e235. 10.3346\/jkms.2018.33.e235","journal-title":"J Korean Med Sci"},{"key":"ref10","article-title":"Scombroid poisoning. Report of an outbreak","volume":"129","author":"Lerke PA","year":"1978","unstructured":"Lerke PA, Werner SB, Taylor SL, Guthertz LS. Scombroid poisoning. Report of an outbreak. West J Med. 1978, 129:381-6.","journal-title":"West J Med"},{"key":"ref11","article-title":"Scombroid fish poisoning in Israel, 2005-2007","volume":"10","author":"Lavon O","year":"2008","unstructured":"Lavon O, Lurie Y, Bentur Y. Scombroid fish poisoning in Israel, 2005-2007. Isr Med Assoc J. 2008, 10:789-92.","journal-title":"Isr Med Assoc J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2021.08.013","article-title":"Histamine and scombrotoxins","volume":"201","author":"Hungerford JM","year":"2021","unstructured":"Hungerford JM. Histamine and scombrotoxins. Toxicon. 2021, 201:115-26. 10.1016\/j.toxicon.2021.08.013","journal-title":"Toxicon"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2010.02.006","article-title":"Scombroid poisoning: a review","volume":"56","author":"Hungerford JM","year":"2010","unstructured":"Hungerford JM. Scombroid poisoning: a review. Toxicon. 2010, 56:231-43. 10.1016\/j.toxicon.2010.02.006","journal-title":"Toxicon"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199103143241102","article-title":"Evidence that histamine is the causative toxin of scombroid-fish poisoning","volume":"324","author":"Morrow JD","year":"1991","unstructured":"Morrow JD, Margolies GR, Rowland J, Roberts LJ 2nd. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med. 1991, 324:716-20. 10.1056\/NEJM199103143241102","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(96)70067-7","article-title":"Scombroid poisoning","volume":"28","author":"Mcinerney J","year":"1996","unstructured":"Mcinerney J, Sahgal P, Vogel M, Rahn E, Jonas E. Scombroid poisoning. Annals Emerg Med. 1996, 28:235-8. 10.1016\/S0196-0644(96)70067-7","journal-title":"Annals Emerg Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/foods9121795","article-title":"An overview of histamine and other biogenic amines in fish and fish products","volume":"9","author":"Visciano P","year":"2020","unstructured":"Visciano P, Schirone M, Paparella A. An overview of histamine and other biogenic amines in fish and fish products. Foods. 2020, 9:1795. 10.3390\/foods9121795","journal-title":"Foods"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413183","article-title":"Molecular mechanisms of eosinophilic esophagitis","volume":"22","author":"Zhernov YV","year":"2021","unstructured":"Zhernov YV, Vysochanskaya SO, Sukhov VA, Zaostrovtseva OK, Gorshenin DS, Sidorova EA, Mitrokhin OV. Molecular mechanisms of eosinophilic esophagitis. Int J Mol Sci. 2021, 22:13183. 10.3390\/ijms222413183","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4236\/oalib.1103992","article-title":"Investigation of contributing factors to scombroid fish poisoning among Dar es Salaam City residents in Tanzania","volume":"4","author":"Bulula N","year":"2017","unstructured":"Bulula N, Mugoyela V, Kaale E. Investigation of contributing factors to scombroid fish poisoning among Dar es Salaam City residents in Tanzania. OALib. 2017, 4:1-16. 10.4236\/oalib.1103992","journal-title":"OALib"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8628-1","article-title":"Urticaria and angioedema: An update on classification and pathogenesis","volume":"54","author":"Radonjic-Hoesli S","year":"2018","unstructured":"Radonjic-Hoesli S, Hofmeier KS, Micaletto S, Schmid-Grendelmeier P, Bircher A, Simon D. Urticaria and angioedema: An update on classification and pathogenesis. Clin Rev Allergy Immunol. 2018, 54:88-101. 10.1007\/s12016-017-8628-1","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12341","article-title":"A consensus parameter for the evaluation and management of angioedema in the emergency department","volume":"21","author":"Moellman JJ","year":"2014","unstructured":"Moellman JJ, Bernstein JA, Lindsell C, et al.. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014, 21:469-84. 10.1111\/acem.12341","journal-title":"Acad Emerg Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2019.07.035","article-title":"Angioedema as a systemic disease","volume":"37","author":"Kazandjieva J","year":"2019","unstructured":"Kazandjieva J, Christoff G. Angioedema as a systemic disease. Clin Dermatol. 2019, 37:636-43. 10.1016\/j.clindermatol.2019.07.035","journal-title":"Clin Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2019.40.4267","article-title":"Hereditary and acquired angioedema","volume":"40","author":"Patel G","year":"2019","unstructured":"Patel G, Pongracic JA. Hereditary and acquired angioedema. Allergy Asthma Proc. 2019, 40:441-5. 10.2500\/aap.2019.40.4267","journal-title":"Allergy Asthma Proc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08841-w","article-title":"Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema","volume":"61","author":"Maurer M","year":"2021","unstructured":"Maurer M, Magerl M. Differences and similarities in the mechanisms and clinical expression of bradykinin-mediated vs. mast cell-mediated angioedema. Clin Rev Allergy Immunol. 2021, 61:40-9. 10.1007\/s12016-021-08841-w","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000233996","article-title":"Dispersion and characterisation of mast cells from human skin","volume":"79","author":"Benyon RC","year":"1986","unstructured":"Benyon RC, Church MK, Clegg LS, Holgate ST. Dispersion and characterisation of mast cells from human skin. Int Arch Allergy Appl Immunol. 1986, 79:332-4. 10.1159\/000233996","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200004000-00026","article-title":"Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells","volume":"92","author":"Veien M","year":"2000","unstructured":"Veien M, Szlam F, Holden JT, Yamaguchi K, Denson DD, Levy JH. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Anesthesiology. 2000, 92:1074-81. 10.1097\/00000542-200004000-00026","journal-title":"Anesthesiology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1385\/CRIAI:30:1:019","article-title":"Drug-induced urticarias","volume":"30","author":"Mathelier-Fusade P","year":"2006","unstructured":"Mathelier-Fusade P. Drug-induced urticarias. Clin Rev Allergy Immunol. 2006, 30:19-23. 10.1385\/CRIAI:30:1:019","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0882-5","article-title":"Angioedema induced by tramadol--a potentially life-threatening condition","volume":"60","author":"Hallberg P","year":"2005","unstructured":"Hallberg P, Brenning G. Angioedema induced by tramadol--a potentially life-threatening condition. Eur J Clin Pharmacol. 2005, 60:901-3. 10.1007\/s00228-004-0882-5","journal-title":"Eur J Clin Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1213\/XAA.0000000000000379","article-title":"A rare case of hydromorphone-induced angioedema effectively managed by a difficult airway response team","volume":"7","author":"Masson S","year":"2016","unstructured":"Masson S, Villerot M, Dalal B. A rare case of hydromorphone-induced angioedema effectively managed by a difficult airway response team. A A Case Rep. 2016, 7:188-9. 10.1213\/XAA.0000000000000379","journal-title":"A A Case Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2012.04.010","article-title":"The safety of codeine in patients with non-steroidal anti-inflammatory drug hypersensitivity: a preliminary study","volume":"41","author":"Celebioglu E","year":"2013","unstructured":"Celebioglu E, Karakaya G, Kalyoncu AF. The safety of codeine in patients with non-steroidal anti-inflammatory drug hypersensitivity: a preliminary study. Allergol Immunopathol (Madr). 2013, 41:163-8. 10.1016\/j.aller.2012.04.010","journal-title":"Allergol Immunopathol (Madr)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2014.03.014","article-title":"Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis","volume":"2","author":"Aun MV","year":"2014","unstructured":"Aun MV, Blanca M, Garro LS, et al.. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis. J Allergy Clin Immunol Pract. 2014, 2:414-20. 10.1016\/j.jaip.2014.03.014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a I","year":"2020","unstructured":"Do\u00f1a I, P\u00e9rez-S\u00e1nchez N, Eguiluz-Gracia I, Mu\u00f1oz-Cano R, Bartra J, Torres MJ, Cornejo-Garc\u00eda JA. Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Allergy. 2020, 75:561-75. 10.1111\/all.14032","journal-title":"Allergy"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2012.10.008","article-title":"Classification of reactions to nonsteroidal antiinflammatory drugs","volume":"33","author":"Kowalski ML","year":"2013","unstructured":"Kowalski ML, Stevenson DD. Classification of reactions to nonsteroidal antiinflammatory drugs. Immunol Allergy Clin North Am. 2013, 33:135-45. 10.1016\/j.iac.2012.10.008","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.06.021","article-title":"Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema","volume":"136","author":"Kowalski ML","year":"2015","unstructured":"Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J Allergy Clin Immunol. 2015, 136:245-51. 10.1016\/j.jaci.2015.06.021","journal-title":"J Allergy Clin Immunol"},{"key":"ref34","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality?","volume":"15","author":"Schubert B","year":"2005","unstructured":"Schubert B, Grosse Perdekamp MT, Pfeuffer P, Raith P, Br\u00f6cker EB, Trautmann A. Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality?. Eur J Dermatol. 2005, 15:164-7.","journal-title":"Eur J Dermatol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203090-00002","article-title":"NSAID-induced urticaria and angioedema: a reappraisal of its clinical management","volume":"3","author":"S\u00e1nchez-Borges M","year":"2002","unstructured":"S\u00e1nchez-Borges M, Capriles-Hulett A, Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol. 2002, 3:599-607. 10.2165\/00128071-200203090-00002","journal-title":"Am J Clin Dermatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2016.08.010","article-title":"Cofactors and comorbidities in patients with aspirin\/NSAID hypersensitivity","volume":"45","author":"S\u00e1nchez-Borges M","year":"2017","unstructured":"S\u00e1nchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Cofactors and comorbidities in patients with aspirin\/NSAID hypersensitivity. Allergol Immunopathol (Madr). 2017, 45:573-8. 10.1016\/j.aller.2016.08.010","journal-title":"Allergol Immunopathol (Madr)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.3273","article-title":"Bradykinin-mediated angioedema","volume":"126","author":"Obtu\u0142owicz K","year":"2016","unstructured":"Obtu\u0142owicz K. Bradykinin-mediated angioedema. Pol Arch Med Wewn. 2016, 126:76-85. 10.20452\/pamw.3273","journal-title":"Pol Arch Med Wewn"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.03.034","article-title":"A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema","volume":"131","author":"Zuraw BL","year":"2013","unstructured":"Zuraw BL, Bernstein JA, Lang DM, et al.. A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol. 2013, 131:1491-3. 10.1016\/j.jaci.2013.03.034","journal-title":"J Allergy Clin Immunol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-018-0859-x","article-title":"ACE inhibitor-induced angioedema: a review","volume":"20","author":"Kostis WJ","year":"2018","unstructured":"Kostis WJ, Shetty M, Chowdhury YS, Kostis JB. ACE inhibitor-induced angioedema: a review. Curr Hypertens Rep. 2018, 20:55. 10.1007\/s11906-018-0859-x","journal-title":"Curr Hypertens Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2022.08.003","article-title":"Isolated angioedema: a review of classification and update on management","volume":"129","author":"Kesh S","year":"2022","unstructured":"Kesh S, Bernstein JA. Isolated angioedema: a review of classification and update on management. Ann Allergy Asthma Immunol. 2022, 129:692-702. 10.1016\/j.anai.2022.08.003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.5152\/balkanmedj.2021.20060","article-title":"Angioedema without wheals: a clinical update","volume":"38","author":"G\u00fclbahar O","year":"2021","unstructured":"G\u00fclbahar O. Angioedema without wheals: a clinical update. Balkan Med J. 2021, 38:73-81. 10.5152\/balkanmedj.2021.20060","journal-title":"Balkan Med J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12997","article-title":"Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: a meta-analysis of randomized controlled trials","volume":"44","author":"Jeon J","year":"2019","unstructured":"Jeon J, Lee YJ, Lee SY. Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: a meta-analysis of randomized controlled trials. J Clin Pharm Ther. 2019, 44:685-92. 10.1111\/jcpt.12997","journal-title":"J Clin Pharm Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312524","article-title":"A randomized trial of icatibant in ACE-inhibitor-induced angioedema","volume":"372","author":"Ba\u015f M","year":"2015","unstructured":"Ba\u015f M, Greve J, Stelter K, et al.. A randomized trial of icatibant in ACE-inhibitor-induced angioedema. N Engl J Med. 2015, 372:418-25. 10.1056\/NEJMoa1312524","journal-title":"N Engl J Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1177\/1060028015607037","article-title":"Off-label use of agents for management of serious or life-threatening angiotensin converting enzyme inhibitor-induced angioedema","volume":"50","author":"Culley CM","year":"2016","unstructured":"Culley CM, DiBridge JN, Wilson GL Jr. Off-label use of agents for management of serious or life-threatening angiotensin converting enzyme inhibitor-induced angioedema. Ann Pharmacother. 2016, 50:47-59. 10.1177\/1060028015607037","journal-title":"Ann Pharmacother"},{"key":"ref45","article-title":"Diagnosis and treatment of hereditary angioedema","volume":"54","author":"Canonica GW","year":"2012","unstructured":"Canonica GW, Rossi O. Diagnosis and treatment of hereditary angioedema. Panminerva Med. 2012, 54:241-53.","journal-title":"Panminerva Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-008295","article-title":"Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department","volume":"2013","author":"Volans A","year":"2013","unstructured":"Volans A, Ferguson R. Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department. BMJ Case Rep. 2013, 2013:bcr2012008295. 10.1136\/bcr-2012-008295","journal-title":"BMJ Case Rep"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3290-z","article-title":"Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant","volume":"40","author":"Charmillon A","year":"2014","unstructured":"Charmillon A, Deibener J, Kaminsky P, Louis G. Angioedema induced by angiotensin converting enzyme inhibitors, potentiated by m-TOR inhibitors: successful treatment with icatibant. Intensive Care Med. 2014, 40:893-4. 10.1007\/s00134-014-3290-z","journal-title":"Intensive Care Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2010.03.032","article-title":"Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series","volume":"56","author":"Bas M","year":"2010","unstructured":"Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, Kojda G. Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med. 2010, 56:278-82. 10.1016\/j.annemergmed.2010.03.032","journal-title":"Ann Emerg Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.09.051","article-title":"Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema","volume":"140","author":"Straka BT","year":"2017","unstructured":"Straka BT, Ramirez CE, Byrd JB, et al.. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema. J Allergy Clin Immunol. 2017, 140:242-8.e2. 10.1016\/j.jaci.2016.09.051","journal-title":"J Allergy Clin Immunol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2017.03.003","article-title":"Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema","volume":"5","author":"Sinert R","year":"2017","unstructured":"Sinert R, Levy P, Bernstein JA, et al.. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema. J Allergy Clin Immunol Pract. 2017, 5:1402-9.e3. 10.1016\/j.jaip.2017.03.003","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac984","article-title":"Three-day icatibant on top of standard care in patients with coronavirus disease 2019 pneumonia: a randomized, open-label, Phase 2, proof-of-concept trial","volume":"76","author":"Malchair P","year":"2023","unstructured":"Malchair P, Giol J, Garc\u00eda V, et al.. Three-day icatibant on top of standard care in patients with coronavirus disease 2019 pneumonia: a randomized, open-label, Phase 2, proof-of-concept trial. Clin Infect Dis. 2023, 76:1784-92. 10.1093\/cid\/ciac984","journal-title":"Clin Infect Dis"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03192-4","article-title":"Bradykinin B(2) receptor blockade and intradialytic hypotension","volume":"24","author":"Gamboa JL","year":"2023","unstructured":"Gamboa JL, Mambungu CA, Clagett AR, Nian H, Yu C, Ikizler TA, Brown NJ. Bradykinin B(2) receptor blockade and intradialytic hypotension. BMC Nephrol. 2023, 24:134. 10.1186\/s12882-023-03192-4","journal-title":"BMC Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/170822-pseudo-allergies-in-the-emergency-department-a-common-misdiagnosis-of-hypersensitivity-type-1-allergic-reaction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:24Z","timestamp":1707509304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/170822-pseudo-allergies-in-the-emergency-department-a-common-misdiagnosis-of-hypersensitivity-type-1-allergic-reaction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,5]]},"references-count":52,"URL":"https:\/\/doi.org\/10.7759\/cureus.46536","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,5]]}}}